Biotechnology, Health Care, Therapeutics
Sengenics
Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
Website
Headquarters
Singapore, Central Region, Singapore
Company Size
51-100
-
OCT 30, 2024 | 8:00 AMC.E. CREDITS
Predicting patient outcomes in cancer treatment is key to creating personalized and effective therapeutic plans. Join Dr. Osman in this engaging webinar as she delves into the cutting-edge w... -
JUN 18, 2024 | 8:00 AM
Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) ornegative (ACPA-). In this webinar, Dr. Sung will present his...
